Recurrent Gastric Adenocarcinoma
2 clinical trials · Condition
◉ Watch Recurrent Gastric Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499) | City of Hope Medical Center | 2019-04-19 |
| MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C (NCT02391038) | Millennium Pharmaceuticals, Inc. | 2014-12-01 |
Track Recurrent Gastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.